logo:Japanese Society of Cancer Nursing

President Message

The Japanese Society of Cancer Nursing (JSCN) was established in 1978. It transitioned into a General Incorporated Association in February 2013, and in December 2020, it became the central science group for cancer nursing, with a membership of over 5,300 in 40 years. One of the features of this academic society is that about 80 percent of its members belong to clinical areas. JSCN aims to ‘"Contribute to people's health and welfare through the development of research, education, and the practice of cancer nursing.”


Health, medical treatment and welfare in Japan have greatly changed because of the coronavirus disease (COVID-19) pandemic. This has had a significant influence on the nursing profession involved with cancer patients and their families, and on cancer medical treatment. At the same time, the number of people with cancer has also been increasing (977,393 people, 2020 Ministry of Health, Labor and Welfare); with 376,425 deaths due to cancer in 2019, cancer remains the primary cause of death in Japan.


The following 7 activities are executed as the main projects of JSCN with a focus on "Prevention of cancer", "Enhancement of the cancer medical treatment", and "Symbiosis with cancer" which are the policy of each field of Basic Plan to Promote Cancer Control Programs based on Cancer Control Act in Japan. The 7 activities are ① holding science meetings, ② publishing journal issues, ③ improving nursing practice and research, ④ collaborating with related science groups domestically and globally, ⑤ conducting international exchange activities, ⑥ contributing to people's health and welfare, ⑦ other items. In the fiscal year 2020, with COVID-19 infection spread, we launched the disaster countermeasure committee, conducted a field study and created homepage about "Information related to COVID-19 special page".


Cancer is a global health issue. During the fiscal years 2018-2020, we attempted to conduct research on “the approach for competency improvement of oncology nurses in Japan for anti-smoking education.” We adopted the “Global bridge Japan project" by collaborating with the International Society of Nurses in Cancer (ISNCC) and Asian Cancer Nursing Society (Asian Oncology Nursing Society: AONS). The results will be shared in the future. In addition, we would like to associate with the profession of cancer medical treatment and also contribute to cancer control measures worldwide in the future.


We considered the future ideal situation of JSCN at the future planning committee in 2020.
In addition to the society’s conventional efforts, promoting and achieving of the future planning of JSCN is a big mission.


Hereafter, cancer medical treatment will continue to make progress, with advances in genome diagnosis, new medicine, and the development of treatment methods. Moreover, there are many problems associated with cancer medical treatment for super low birthrates and aging. In the clinical area, based on the average length of hospital stay and categorizing functional status, the opportunity of a continued relationship with patients and their family members is decreasing. Simply because it is now, nursing practice for patients and family members who spend the satisfied days while balancing with the medical treatment and social life is required.


JSCN aims to promote high-quality cancer nursing practice, education, and research, and will make its proposals for cancer policies and systems in future.


Those who wish to learn more about cancer nursing in detail, please take a look at this homepage, as all the necessary information can be obtained from this homepage. The activity of JSCN will make progress while receiving the support from members of JSCN and all individuals.
Thank you for your cooperation and support.


February, 2021
Mari Watanabe
President of the Japanese Society of Cancer Nursing